Complete Genomics to Announce New Product Launches at AGBT General Meeting
SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"), today announced it plans to launch three new products at the Advances in Genome Biology and Technology (AGBT) General Meeting on February 6-9 in Hollywood, Florida. The Company will launch an ultra-high-speed sequencer with...
Strava Acquires Outdoor Adventure Platform, FATMAP
The subscription platform continues to deliver a best-in-class digital experience meant to inspire and motivate their active community with the addition of FATMAP's 3D mapping technology making outdoor adventures easier to discover, experience and share SAN FRANCISCO, Jan. 24, 2023 /PRNewswire/ -- Strava, the subscription platform at the center of connected fitness, announced the acquisition of FATMAP,...
2023 Japan Prize Laureates Announced
TOKYO, Jan. 24, 2023 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2023 Japan Prize on January 24, 2023. Prof. Masataka Nakazawa and Mr. Kazuo Hagimoto, both of Japan, are co-winners of the Japan Prize in the fields of Electronics, Information, and Communication, and Prof. Gero Miesenboeck of Austria and Prof. Karl Deisseroth of the United States...
South Australia’s health system and The Clinician partner to deliver State-wide Patient Reported Measures Program
South Australia's Commission on Excellence and Innovation in Health and SA Health have partnered with The Clinician to implement a digital solution for the state-wide collection and analysis of patient reported outcome and experience measures (PROMs and PREMs). ADELAIDE, Australia, Jan. 24, 2023 /PRNewswire/ -- South Australia's Commission on Excellence and Innovation in...
ACCEPTANCE PERIOD FOR EXCHANGE OFFER EXTENDED PENDING COMPETITION CLEARANCES
THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS This is a joint press release by Koninklijke DSM N.V. (DSM),...
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal and brain tumors. Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a...
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination
NEW YORK, Jan. 21, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ: UPTD) today announced that, in order to extend the date by which the Company mush complete its initial business combination from January 19, 2023 to February 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with...
BIOMERICS COMPLETES CONNECTICUT EXPANSION
SALT LAKE CITY, Jan. 20, 2023 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced completion of a 26,000 sq. ft. expansion of its Monroe, CT facility. The Monroe facility is the headquarters of Biomerics' micro-metals processing business and specializes in the design, development,...
CARsgen Presents Results on Anti-Claudin18.2-mAb AB011 at ASCO GI
SHANGHAI, Jan. 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that a poster presentation highlighting the Phase 1 preliminary results of a recombinant humanized anti-claudin18.2 monoclonal antibody (AB011), as monotherapy and...
China Jo-Jo Drugstores Announces $2.625 Million Registered Direct Offering
HANGZHOU, China, Jan. 20, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1.75 million ordinary shares,...
